AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

New Approaches for Evaluating the Interchangeability of Reference Materials and Quality Controls (COMET-MPL)

Recruitingn/aAges 18 Years - anyAllUniversity Hospital, Montpellier
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Medical biology tests are essential to clinical decision-making. The European Regulation on in vitro diagnostic medical devices (EU/2017/746) requires metrological traceability of the values assigned to calibrators and quality controls, based on reference measurement methods (RMMs) or certified reference materials (CRMs). However, these references are not available for all analyses, limiting manufacturers' ability to comply with regulatory requirements. The dissemination of traceability relies mainly on CRMs. However, to guarantee the validity of the results, these materials must have sufficient commutability, i.e., behavior comparable to that of native biological samples. This property is also required for external quality controls (EQA) used in external quality control programs. Commutability is an essential condition for avoiding matrix effects and ensuring the reliability of results

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Panel 1: adults โ‰ฅ 18 years of age. * Panel 2: adults โ‰ฅ 18 years of age undergoing immunosuppressive treatment (cyclosporine, everolimus, tacrolimus, sirolimus). Exclusion Criteria: * Protected patients (minors who are not emancipated, individuals who are unable to express their consent, etc.) * Individuals who are not affiliated with a social security system * Individuals under judicial protection * Refusal to give consent to participate in the research
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

2 sites
University Hospital Montpellier
Montpellier, France
University Hospital, Montpellier
Montpellier, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy